Why UroGen Pharma Ltd. (URGN) stock rose 7.3% on Monday, November 16, 2026
UroGen Pharma Ltd. (URGN) closed at $28.1, up 7.33% on Monday, November 16, 2026, on volume of 3,849,602 shares (3.8× its 3-month average); market value about $1.40B, according to Nexqual market data (nexqual.com/moves/2026-11-16/URGN).
What happened
Nexqual found no SEC filing, earnings release, analyst rating change or insider trade for URGN on Monday, November 16, 2026 or November 13, 2026. The move may reflect news, sector or market moves, or trading flows that these sources do not capture.
More on URGN
URGN stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. Other big moves that day: November 16, 2026.
Sources: SEC EDGAR, Nexqual Earnings Flash, analyst rating changes, Nexqual market data. Built November 18, 2026 at 20:49 UTC. Not investment advice.
Data source: Nexqual. Last updated: November 18, 2026 at 20:49 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt